H-DL-Tyr-DL-Glu-DL-Glu-DL-Lys-OH
C25H37N5O10 — CID 19952114
Data last refreshed: (MolForge compound catalog, from PubChem)
About H-DL-Tyr-DL-Glu-DL-Glu-DL-Lys-OH
H-DL-Tyr-DL-Glu-DL-Glu-DL-Lys-OH (PubChem CID 19952114) has the molecular formula C25H37N5O10 and a molecular weight of 567.60 g/mol. Its IUPAC name is 6-amino-2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]hexanoic acid.
Molecular Properties
| Compound Name | H-DL-Tyr-DL-Glu-DL-Glu-DL-Lys-OH |
|---|---|
| PubChem CID | 19952114 |
| Molecular Formula | C25H37N5O10 |
| Molecular Weight | 567.60 g/mol |
| Exact Mass | 567.25 |
| IUPAC Name | 6-amino-2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]hexanoic acid |
| SMILES | NCCCCC(NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)O |
| InChI | InChI=1S/C25H37N5O10/c26-12-2-1-3-19(25(39)40)30-24(38)18(9-11-21(34)35)29-23(37)17(8-10-20(32)33)28-22(36)16(27)13-14-4-6-15(31)7-5-14/h4-7,16-19,31H,1-3,8-13,26-27H2,(H,28,36)(H,29,37)(H,30,38)(H,32,33)(H,34,35)(H,39,40) |
| InChIKey | RNWODFGLNQVFSE-UHFFFAOYSA-N |
| XLogP | -1.34 |
| TPSA | 271.47 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 567.60 |
| LogP ≤ 5 | -1.34 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 19952114 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.